To investigate the influence of the AFAP1‐AS1 ORF2 peptide and lncRNA on cancer progression, we constructed an A549 cell line with a genome harboring the 1311–1315 GGACC mutation using the CRISPR/Cas9 method with donor DNA (Figure 3K). The gene discussed is AFAP1; the disease is cancer.